Evaluation of Safety and Immunogenicity of BNT162B2 mRNA COVID-19 Vaccine in IBD Pediatric Population with Distinct Immune Suppressive Regimens

Patients affected by Inflammatory Bowel Disease (IBD) present higher risk for infection and suboptimal response upon vaccination. The immunogenicity of SARS-CoV2 vaccination is still largely unknown in adolescents or young adults affected by IBD (pIBD). We investigated the safety and immunogenicity...

Descripción completa

Detalles Bibliográficos
Autores principales: Cotugno, Nicola, Franzese, Enrica, Angelino, Giulia, Amodio, Donato, Romeo, Erminia Francesca, Rea, Francesca, Faraci, Simona, Tambucci, Renato, Profeti, Elisa, Manno, Emma Concetta, Santilli, Veronica, Rotulo, Gioacchino Andrea, Pighi, Chiara, Medri, Chiara, Morrocchi, Elena, Colagrossi, Luna, Pascucci, Giuseppe Rubens, Valentini, Diletta, Villani, Alberto, Rossi, Paolo, De Angelis, Paola, Palma, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318731/
https://www.ncbi.nlm.nih.gov/pubmed/35891273
http://dx.doi.org/10.3390/vaccines10071109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318731/
https://www.ncbi.nlm.nih.gov/pubmed/35891273
http://dx.doi.org/10.3390/vaccines10071109

Ejemplares similares